NDC 53401-022 – Terazosin

Terazosin Hydrochloride 1 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC53401-022

Product details

Brand name
Terazosin
Generic name
Terazosin
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA075614
Marketed since
April 30, 2021
Listing expires
December 31, 2027
Pharmacologic class
alpha-Adrenergic Blocker

Active ingredients

Uses, dosage, side effects and warnings for Terazosin →

Package NDC codes (2)

Package NDCDescriptionSince
53401-022-5360 CAPSULE in 1 BOTTLE (53401-022-53)Jul 20, 2026
53401-022-6090 CAPSULE in 1 BOTTLE (53401-022-60)Jul 20, 2026

Other Terazosin products